Evidence map›Paper›PMID 28149294›Full record

ArticleFrontiers in microbiology2017

MLVA Genotyping Characteristics of Human

Zhi-Guo Liu, Dong-Dong Di, Miao Wang, Ri-Hong Liu, Hong-Yan Zhao, Dong-Ri Piao, Guo-Zhong Tian, Wei-Xing Fan, Hai Jiang, Bu-Yun Cui and 1 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. MultipleFrontiers in cellular and infection microbiology · 2024
    Article
  8. Article
  9. Native circulatingFrontiers in microbiology · 2023
    Article
  10. Molecular epidemiological characteristics ofFrontiers in microbiology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Emerging microbes & infections · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhi-Guo LiuCollege of Veterinary Medical Inner Mongolia Agriculture UniversityHohhot, China; Ulanqab Centre for Endemic Disease Prevention and Control, Health and Family Planning Commission of UlanqabJining, China.
Dong-Dong DiLaboratory of Zoonoses, China Animal Health and Epidemiology Center MOA, Qingdao, China.
Miao WangUlanqab Centre for Endemic Disease Prevention and Control, Health and Family Planning Commission of Ulanqab Jining, China.
Ri-Hong LiuUlanqab Centre for Endemic Disease Prevention and Control, Health and Family Planning Commission of Ulanqab Jining, China.
Hong-Yan ZhaoState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Dong-Ri PiaoState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Guo-Zhong TianState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Wei-Xing FanLaboratory of Zoonoses, China Animal Health and Epidemiology Center MOA, Qingdao, China.
Hai JiangState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Bu-Yun CuiState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Xian-Zhu XiaCollege of Veterinary Medical Inner Mongolia Agriculture UniversityHohhot, China; Institute of Military Veterinary AMMSChangchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brucellosis is a serious public health problem in Ulanqab, which is a region located in the middle of the Inner Mongolia Autonomous Region adjacent to Shanxi and Hebei provinces. The disease is prevalent in both the latter provinces and Ulanqab with the highest prevalence of brucellosis occurring in Inner Mongolia. The MLVA-16 scheme is a genotyping tool for assessing genetic diversity and relationships among isolates. Moreover, this genotyping tool can also be applied to epidemiological trace-back investigations. This study reports the occurrence of at least two

Indexed as

Brucella melitensisInner MongoliaMLVAmolecular epidemiologytrace-back analysisUlanqab

Identifiers

PMID28149294
PMCPMC5241320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.